Monoamine Oxidase Inhibitors in Bipolar Endogenous Depressives

  title={Monoamine Oxidase Inhibitors in Bipolar Endogenous Depressives},
  author={F. Quitkin and P. McGrath and M. Liebowitz and J. Stewart and A. Howard},
  journal={Journal of Clinical Psychopharmacology},
Clinical lore suggests that monoamine oxidase inhibitors (MAOIs) are not effective in endogenous depression. A review of previous placebo-controlled trials of MAOI in patients with endogenous depression neither refutes nor confirms their utility in this patient group. We present patients in the depressive phase of bipolar illness refractory to treatment with tricyclics who have responded to MAOI. These open trials require confirmation in controlled studies. Bipolar illness may be a… Expand
36 Citations
A clinical overview of monoamine oxidase inhibitors.
  • S. Zisook
  • Psychology, Medicine
  • Psychosomatics
  • 1985
  • 56
Efficacy of reversible inhibitors of monoamine oxidase‐A in various forms of depression
  • 49
Induction of mania with serotonin reuptake inhibitors.
  • R. Howland
  • Medicine
  • Journal of clinical psychopharmacology
  • 1996
  • 131
  • PDF
Tranylcypromine in depression resistant to cyclic antidepressions
  • W. Nolen
  • Psychology, Medicine
  • Progress in Neuro-Psychopharmacology and Biological Psychiatry
  • 1989
  • 11
Predictors of drug response in depression.
  • 275
The pharmacologic treatment of depression.
  • 162
Bipolar depression: treatment options.
  • 54
Treatment of Acute Bipolar Depression: A Review of the Literature
  • 41